Clinical Trial Update: Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of a combination therapy for untreated metastatic pancreatic ductal adenocarcinoma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: HonorHealth Research Institute | Conditions: Untreated Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-12-10